Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,4011,420 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2026

Targeting the prostate-specific membrane antigen (PSMA) with small molecules for imaging and therapy of prostate cancer (PC) has revitalized the field of nuclear medicine. Few targ...

$4.29M
USD
Active TRAINING, INDIVIDUAL
The role of CCR6 in Pancreatic Cancer and Tregs
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2024 – 2028

PROJECT SUMMARY Pancreatic cancer has a dismal average life expectancy of around six months, in large part due to the marked immunosuppression surrounding the tumor preventing an a...

$510.6K
USD
Active NON-SBIR/STTR RPGS
Optimizing TCR-CD3 signaling for immunotherapy of cancer
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

ABSTRACT The recent development of T cell-based cancer immunotherapies, including checkpoint blockade (anti-PD-1, anti-CTLA-4 and others) or adoptive T cell therapy (ACT) using mod...

$6.53M
USD
Active NON-SBIR/STTR RPGS
Uncovering Oncogenotype-specific Vulnerabilities in Lung cancer
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

PROJECT SUMMARY Given the important roles of tumor suppressors and oncogenes in metabolic reprogramming, there is significant translational potential in identifying and understandi...

$4.8M
USD
Active TRAINING, INDIVIDUAL
Elacestrant in breast cancer bone metastases
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2027

PROJECT SUMMARY Estrogen receptor (ER) signaling is the main driver of tumorigenesis in ER+ breast cancers by inducing proliferation and survival through genomic and non-genomic me...

$434K
USD
Completed OTHER RESEARCH-RELATED
The Midwest Tumor Microenvironment Meeting
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2025

PROJECT SUMMARY We request partial funding for the Midwest Tumor Microenvironment Meeting to be held at the University of Wisconsin-Madison Pyle Center in Madison, WI on May 20-22,...

$100K
USD
Active NON-SBIR/STTR RPGS
Posttranslational modifications of glucocorticoid receptor associated with drug-resistance in prostate cancer
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2024 – 2029

PROJECT SUMMARY (ABSTRACT) An evolving concept that contributes to our understanding of resistance to androgen deprivation therapy (ADT) or androgen receptor (AR) antagonists in ad...

$6.42M
USD
Active NON-SBIR/STTR RPGS
Mechanisms of APOBEC3A-induced cancer evolution and cancer vulnerability
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Cancer evolution driven by DNA-mutating APOBEC enzymes (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like), and the emergence of resistance...

$5.45M
USD
Active TRAINING, INDIVIDUAL
Investigating the role of G-protein coupled estrogen receptor expression on cancer associated fibroblasts in therapy resistant ER+ breast cancer progression
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2027

Project Summary/Abstract Estrogen receptor positive (ER+) breast cancer (BC) accounts for the majority of all diagnosed BC for women in the United States. While traditional antihor...

$360.4K
USD
Active OTHER RESEARCH-RELATED
BCOR/PRC1.1 Inactivation In Splicing Factor Mutant MDS Progression
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY: Myeloid malignancy is characterized by the acquisition of mutations in a stereotyped order with distinct patterns of cooperating mutations. Mutations in genes that...

$2.51M
USD
Completed NON-SBIR/STTR RPGS
Disentangling the effect of Black/African Ancestry from confounding variables on colorectal cancer biology
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2024 – 2026

SUMMARY There is a higher incidence and mortality of colorectal cancer (CRC) in individuals self-identifying as Black race compared to all other races and ethnicities in the US. Pr...

$941.2K
USD
Active NON-SBIR/STTR RPGS
Mechanism and therapeutic targeting of abnormal androgenesis in CHD1-deficient prostate cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

PROJECT SUMMARY Androgen receptor (AR) signaling is a major driver of prostate cancer (PCa) progression. Persistent activation of AR due to aberrant intratumoral androgen synthesis...

$4.52M
USD
Active NON-SBIR/STTR RPGS
Clinical and pre-clinical investigation of extracellular vesicles as a mechanism of toxicity in the bladder of prostate cancer patients treated with radiotherapy
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2029

We propose to study extracellular vesicles (EVs) as novel mediators of the pathogenesis of radiation cystitis (RC), which affects approximately 15% of prostate cancer (PCa) patient...

$4.49M
USD
Active NON-SBIR/STTR RPGS
SPECTRUM (Studying PRIDE to Enhance Cancer screening guidelines for TRansgender Users of gender-affirMing hormones)
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

SUMMARY Transgender (TG) men (assigned female at birth) and TG women (assigned male at birth) comprise a vulnerable population whose health is largely understudied. Approximately 7...

$6.95M
USD
Active NON-SBIR/STTR RPGS
Impact of Cancer on Cognitive Trajectories in Older Adults
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY Cancer-related cognitive impairment (CRCI) represents an important clinical issue affecting up to 75% of people before, during, and after diagnosis and treatment. U...

$5.27M
USD
Completed NON-SBIR/STTR RPGS
Roles of gut-breast axis in breast pathophysiology
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2024 – 2026

Microbiome impacts cancer development and therapeutic efficacy. In addition to the guts, microbes reside in different tissues influencing the pathophysiology of the tissue microenv...

$2.26M
USD
Active NON-SBIR/STTR RPGS
TROP2-Directed CAR-NK Cells for the Immunotherapy of Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

SUMMARY/ ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a 5-year survival rate of only ~12%. Therefore, there is a critical unmet need for new treatm...

$3.71M
USD
Completed NON-SBIR/STTR RPGS
Understanding patient-surgeon interactions to support deimplementation of preference-sensitive low value care
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2026

Project Summary/Abstract Breast surgeons have been highly successful at deimplementing some low-value surgical care but less successful at deimplementing care that is preference-se...

$1.95M
USD
Active NON-SBIR/STTR RPGS
Targeting hTERT/telomerase for managing acquired resistance to third generation EGFR-TKIs in lung cancer
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

SUMMARY The ability of cancer cells to acquire resistance to anticancer drugs, resulting in eventual treatment failure, is one of the most challenging problems in cancer therapy. O...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Novel approaches to target KEAP1 mutant tumors
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Treating KRAS mutant lung adenocarcinoma (LUAD) remains a major challenge for clinical oncology. Approximately 20% of KRAS mutant LUAD tumors carry loss-of...

$6.76M
USD